1. Home
  2. OCSL vs NEO Comparison

OCSL vs NEO Comparison

Compare OCSL & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • NEO
  • Stock Information
  • Founded
  • OCSL 2007
  • NEO 2001
  • Country
  • OCSL United States
  • NEO United States
  • Employees
  • OCSL N/A
  • NEO N/A
  • Industry
  • OCSL Finance: Consumer Services
  • NEO Precision Instruments
  • Sector
  • OCSL Finance
  • NEO Health Care
  • Exchange
  • OCSL Nasdaq
  • NEO Nasdaq
  • Market Cap
  • OCSL 1.1B
  • NEO 1.2B
  • IPO Year
  • OCSL 2008
  • NEO 1999
  • Fundamental
  • Price
  • OCSL $13.54
  • NEO $10.41
  • Analyst Decision
  • OCSL Hold
  • NEO Buy
  • Analyst Count
  • OCSL 6
  • NEO 10
  • Target Price
  • OCSL $15.20
  • NEO $12.56
  • AVG Volume (30 Days)
  • OCSL 871.3K
  • NEO 4.9M
  • Earning Date
  • OCSL 11-18-2025
  • NEO 10-28-2025
  • Dividend Yield
  • OCSL 11.62%
  • NEO N/A
  • EPS Growth
  • OCSL N/A
  • NEO N/A
  • EPS
  • OCSL 0.55
  • NEO N/A
  • Revenue
  • OCSL $334,099,000.00
  • NEO $709,162,000.00
  • Revenue This Year
  • OCSL N/A
  • NEO $10.74
  • Revenue Next Year
  • OCSL N/A
  • NEO $9.85
  • P/E Ratio
  • OCSL $25.19
  • NEO N/A
  • Revenue Growth
  • OCSL N/A
  • NEO 10.10
  • 52 Week Low
  • OCSL $12.44
  • NEO $4.72
  • 52 Week High
  • OCSL $16.53
  • NEO $19.12
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 49.00
  • NEO 60.87
  • Support Level
  • OCSL $13.49
  • NEO $9.42
  • Resistance Level
  • OCSL $14.05
  • NEO $10.58
  • Average True Range (ATR)
  • OCSL 0.25
  • NEO 0.58
  • MACD
  • OCSL -0.02
  • NEO -0.07
  • Stochastic Oscillator
  • OCSL 37.52
  • NEO 48.47

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: